Creative Commons source reading · Women and female-athlete health
2025 Update to the Female Athlete Triad Coalition Consensus Statement Part 2: Clinical Guidelines for Screening, Diagnosis, Treatment, and Return to Play for Adolescents and Adults
Williams NI; De Souza MJ; Misra M; Nattiv A; Joy E; Barrack M; Ricker EA; Gorrell S; Koltun KJ; O'Donnell E; Mallinson RJ; Salamunes ACC; Woodruff K; Fredericson M; Plessow F
Originally published in Sports Med · 2025-12-31
From the article
Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.
Abstract
AbstractThis is the second of two publications comprising the 2025 update to the 2014 Consensus Statement on treatment and return to play guidelines on the Female Athlete Triad (Triad). This paper pairs with the 2025 Update to the Female Athlete Triad Coalition Consensus Statement Part 1: State of the Science and Introduction of a New Adolescent Model (Sports Medicine, 2025), to focus on evidence-based revisions for screening, diagnosis, treatment, and clearance and return to play. Revised recommendations for managing eating disorders (ED)/disordered eating (DE) and non-pharmacological and pharmacological treatment of bone loss and abnormal menstrual cycles are included, as are the most recent clearance and return to play recommendations, inclusive of adolescent athletes. Recent research supports the adoption of revised criteria for…
Conclusion
The 2025 Update to the Female Athlete Triad Coalition Consensus Statement Part 2 provides the most current and evidence-based information on the prevention, treatment, and return to play decision making pertaining to girls and women with Triad conditions. These recommendations reflect advances in Triad science and supersede the previous 2014 Triad Consensus Statement [4]. Clinicians, researchers, and sports medicine practitioners are also referred to the 2025 Update to the Female Athlete Triad Coalition Consensus Statement Part 1 [1] companion paper for a more in-depth review of the scientific basis of these clinical guidelines.
Editorial reading guide
- Was the study designed for the population to which its conclusion is applied?
- What safeguard, access need or equity consequence should shape implementation?
